11/07/2024
12:15 PM | Athira Pharma (Subject)
BML Investment Partners, L.P. (Filed by)
| Form SC 13G | |
10/31/2024
3:16 PM | Athira Pharma (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
| Form SC 13D/A | |
10/28/2024
11:15 PM | Athira Pharma (Filer)
| Form EFFECT | |
10/21/2024
5:24 AM | Athira Pharma (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
10/03/2024
8:50 PM | Athira Pharma (Issuer)
Litton Mark James (Reporting)
| Form 4/A | |
10/03/2024
6:07 PM | Athira Pharma (Issuer)
Litton Mark James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2024
6:08 PM | Athira Pharma (Issuer)
Worthington Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
10/03/2024
6:10 PM | Athira Pharma (Issuer)
CHURCH KEVIN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2024
6:13 PM | Athira Pharma (Issuer)
San Martin Javier (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2024
6:17 PM | Athira Pharma (Issuer)
Renninger Robert (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2024
6:05 PM | Athira Pharma (Issuer)
Renninger Robert (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/17/2024
8:00 AM | Athira Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/05/2024
6:47 PM | Athira Pharma (Issuer)
Litton Mark James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
6:48 PM | Athira Pharma (Issuer)
Worthington Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
6:49 PM | Athira Pharma (Issuer)
CHURCH KEVIN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
6:50 PM | Athira Pharma (Issuer)
Lenington Rachel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
6:51 PM | Athira Pharma (Issuer)
Gengos Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
6:53 PM | Athira Pharma (Subject)
Litton Mark James (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/01/2024
3:15 PM | Athira Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
06/25/2024
6:21 PM | Athira Pharma (Issuer)
Romano Kelly A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
3:05 PM | Athira Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/24/2024
5:54 PM | Athira Pharma (Issuer)
FLUKE JOHN M JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2024
5:55 PM | Athira Pharma (Issuer)
PICKERING GRANT (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2024
5:56 PM | Athira Pharma (Issuer)
Panzara Michael A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2024
5:58 PM | Athira Pharma (Issuer)
Kosacz Barbara (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2024
6:00 PM | Athira Pharma (Issuer)
JOHNSON JAMES A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2024
6:01 PM | Athira Pharma (Issuer)
EDELMAN JOSEPH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2024
6:03 PM | Athira Pharma (Issuer)
Romano Kelly A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/16/2024
3:34 PM | Athira Pharma (Issuer)
San Martin Javier (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/16/2024
3:37 PM | Athira Pharma (Issuer)
San Martin Javier (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/09/2024
7:32 AM | Athira Pharma (Filer)
| Form DEF 14A | |
04/09/2024
7:34 AM | Athira Pharma (Filer)
| Form DEFA14A | |
04/09/2024
7:35 AM | Athira Pharma (Filer)
| Form ARS | |
03/28/2024
7:47 AM | Athira Pharma (Filer)
| Form PRE 14A | |
02/22/2024
3:34 PM | Athira Pharma (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/22/2024
3:15 PM | Athira Pharma (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/16/2024
3:46 PM | Athira Pharma (Issuer)
Lenington Rachel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
3:48 PM | Athira Pharma (Issuer)
Gengos Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
3:54 PM | Athira Pharma (Issuer)
CHURCH KEVIN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
3:32 PM | Athira Pharma (Issuer)
CHURCH KEVIN (Reporting)
| Form 4/A | |
02/16/2024
3:34 PM | Athira Pharma (Issuer)
Gengos Andrew (Reporting)
| Form 4/A | |
I've got news for you… (Ad) Today, I’m doing something I thought I’d never do…
Especially since I’m not normally a “swing for the fences” type of trader.
But I’ve been quietly testing a new type of trade for a while now…
And the returns are too good not to share with you.
Take a look…
I can’t guarantee results or against losses, but if you want to discover how I’ll target the triple return before the end of the week watch this FREE briefing with me and expert trader Graham Lindman |
02/16/2024
3:37 PM | Athira Pharma (Issuer)
Worthington Mark (Reporting)
| Form 4/A | |
02/16/2024
3:38 PM | Athira Pharma (Issuer)
Litton Mark James (Reporting)
| Form 4/A | |
02/16/2024
3:40 PM | Athira Pharma (Issuer)
Lenington Rachel (Reporting)
| Form 4/A | |
01/08/2024
3:36 PM | Athira Pharma (Issuer)
CHURCH KEVIN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2024
3:38 PM | Athira Pharma (Issuer)
Worthington Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2024
3:40 PM | Athira Pharma (Issuer)
Litton Mark James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2024
3:42 PM | Athira Pharma (Issuer)
Gengos Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2024
3:45 PM | Athira Pharma (Issuer)
MOEBIUS HANS (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2024
3:35 PM | Athira Pharma (Issuer)
Lenington Rachel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2024
6:11 AM | Athira Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/29/2023
4:24 PM | Athira Pharma (Issuer)
EDELMAN JOSEPH (Reporting)
PERCEPTIVE ADVISORS LLC (Reporting)
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/29/2023
4:15 PM | Athira Pharma (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
| Form SC 13D/A | |
Free ATHA Stock Alerts